|
Volumn 10, Issue SUPPL. 1, 2005, Pages 12-18
|
Belara® - A reliable oral contraceptive with additional benefits for health and efficacy in dysmenorrhoea
|
Author keywords
Acne; Compliance; Dysmenorrhea; Ethinylestradiol chlormadinone acetate; Menstrual irregularities; Oral contraceptive
|
Indexed keywords
CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL;
GESTAGEN;
ORAL CONTRACEPTIVE AGENT;
CHLORMADINONE ACETATE;
ETHINYLESTRADIOL;
ACNE;
BODY WEIGHT;
BREAKTHROUGH BLEEDING;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONFIDENCE INTERVAL;
DEPRESSION;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG USE;
DYSMENORRHEA;
GASTROINTESTINAL SYMPTOM;
HEALTH;
HUMAN;
LIBIDO DISORDER;
MASTALGIA;
MENSTRUAL CYCLE;
MENSTRUATION;
ORAL CONTRACEPTION;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RELIABILITY;
REMISSION;
SEBORRHEA;
SIDE EFFECT;
TREATMENT OUTCOME;
WEIGHT CHANGE;
ACNE VULGARIS;
ARTICLE;
FEMALE;
POSTMARKETING SURVEILLANCE;
SEBORRHEIC DERMATITIS;
ACNE VULGARIS;
CHLORMADINONE ACETATE;
CONTRACEPTIVES, ORAL;
DERMATITIS, SEBORRHEIC;
DYSMENORRHEA;
ETHINYL ESTRADIOL;
FEMALE;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
|
EID: 29044442795
PISSN: 13625187
EISSN: 14730782
Source Type: Journal
DOI: 10.1080/13625180500434897 Document Type: Conference Paper |
Times cited : (19)
|
References (6)
|